AI assistant
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2024
Jun 25, 2024
30849_dirs_2024-06-25_34471b36-0776-4526-ac0b-e059b57dbd51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2024-06-21
Reporting Person: Mathers Edward T (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-21 | Common Stock | M | 3000 | — | Acquired | 3000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-21 | Restricted Stock Units | $ | M | 3000 | Disposed | Common Stock (3000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 5771 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2: The Reporting Person is the trustee of the Edward Timothy Mathers Revocable Trust (the "Mathers Trust"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.
F3: The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date.